Lass Jonathan H

Ahmed Iqbal Ike K, Sheybani Arsham, De Francesco Ticiana, Lass Jonathan H, Benetz Beth Ann, Samuelson Thomas W et al.

This 5-year study found iStent inject with phacoemulsification for glaucoma had no device-related complications or worse endothelial cell loss than phacoemulsification alone, demonstrating long-term corneal safety.

Lass Jonathan H, Benetz Beth Ann, He Jonathan, Hamilton Cody, Von Tress Mark, Dickerson Jaime et al.

This study found CyPass Micro-Stent implantation with phacoemulsification causes greater, prolonged corneal endothelial cell loss than phacoemulsification alone, though clinical signs were uncommon, suggesting subclinical impact.

Sugar Alan, Gal Robin L, Kollman Craig, Raghinaru Dan, Dontchev Mariya, Croasdale Christopher R et al.

This study found corneal graft survival at 10 years is significantly lower in patients with pseudophakic corneal edema and pre-existing glaucoma, highlighting these as critical risk factors for graft failure.